2 results
Approved WMOPending
To achieve earlier sport resumption in more patients due to PEMFs compared to placebo.
Approved WMOCompleted
To determine if treatment with infigratinib improves centrally reviewed disease-free survival (DFS) compared with placebo treatment in subjects with invasive urothelial carcinoma with susceptible FGFR3 alterations after nephroureterectomy, distal…